GSTs are significant in cancer because they contribute to the detoxification of chemotherapeutic agents, leading to drug resistance. High levels of GSTs have been associated with poor prognosis in several cancer types, including lung, breast, and liver cancer. Inhibiting GSTs can enhance the efficacy of chemotherapy by reducing drug resistance.
